Phase 1 Advanced malignant solid tumors Clinical Trials
13 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–13 of 13 trials
Recruiting
Phase 1
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Colorectal, CancerMesothelin-Expressing TumorsEpithelial Ovarian Cancer+8 more
Context Therapeutics Inc.70 enrolled9 locationsNCT06756035
Recruiting
Phase 1
Trial to Assess the Safety and Antitumor Activity of GEN1057 in Malignant Solid Tumors
Advanced malignant solid tumorsMetastatic Malignant Solid Tumors
Genmab45 enrolled5 locationsNCT06573294
Recruiting
Phase 1Phase 2
A Study of FC084CSA in Combination of Tislelizumab in Patients With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
FindCure Biosciences (ZhongShan) Co., Ltd.33 enrolled1 locationNCT06499350
Recruiting
Phase 1
A Study of CSCJC3456 in Patients With Advanced Malignant Tumors
Advanced malignant solid tumors
Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.102 enrolled2 locationsNCT06717750
Recruiting
Phase 1
JSKN022 in Subjects With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Jiangsu Alphamab Biopharmaceuticals Co., Ltd225 enrolled1 locationNCT07292402
Recruiting
Phase 1
MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors
B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors
Zhejiang University12 enrolled1 locationNCT06912152
Recruiting
Phase 1
Phase I Study of WJ47156 Monotherarpy and in Combination With Other Therapy in Advanced Solid Tumors
Advanced malignant solid tumors
Shanghai Junshi Bioscience Co., Ltd.93 enrolled1 locationNCT06571422
Recruiting
Phase 1Phase 2
A Study of GQ1010 in Subjects With Advanced Solid Tumors
Advanced malignant solid tumors
GeneQuantum Healthcare (Suzhou) Co., Ltd.260 enrolled5 locationsNCT06464055
Recruiting
Phase 1
A Clinical Research About CD70-targeted CAR-NKT Cells Therapy in Subjects with Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Peking University Cancer Hospital & Institute13 enrolled1 locationNCT06728189
Recruiting
Phase 1
A Clinical Study of 9MW2821 in Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Mabwell (Shanghai) Bioscience Co., Ltd.40 enrolled2 locationsNCT05773937
Recruiting
Phase 1
Anti-CDH17 CAR-T Cell Injection in Patients With CDH17-positive Advanced Malignant Solid Tumors
CDH17-positive Advanced Malignant Solid Tumors
Shanghai Pudong Hospital17 enrolled1 locationNCT06501183
Recruiting
Phase 1
A Study of HMPL-415S1 in Patients With Advanced Malignant Solid Tumors
Advanced malignant solid tumors
Hutchmed81 enrolled1 locationNCT05886374
Terminated
Phase 1
A first-in-human study of VG161 in participants with advanced malignant tumours that have not responded to conventional therapies.
Advanced malignant solid tumors
Virogin Biotech Australia Pty. Ltd.36 enrolled3 locationsACTRN12620000244909